| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.16 | 0.003 |